This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Renal Cancer
Recent Abstracts
New targeted therapies for renal cell carcinoma - Abstract
May 11, 2011
What can molecular pathology contribute to the management of renal cell carcinoma? - Abstract
May 10, 2011
Cigarette smoking is associated with advanced renal cell carcinoma - Abstract
May 10, 2011
Expression level of vascular endothelial growth factor receptor-2 in radical nephrectomy specimens as a prognostic predictor in patients with metastatic renal cell carcinoma treated with sunitinib - Abstract
May 9, 2011
Treatment of metastatic renal cell carcinoma and renal pelvic cancer - Abstract
May 7, 2011
Insertion/deletion polymorphism of angiotensin I-converting enzyme gene is linked with chromophobe renal cell carcinoma - Abstract
May 6, 2011
Looking beyond inhibition of VEGF/mTOR: Emerging targets for renal cell carcinoma drug development - Abstract
May 5, 2011
Subclavian vein thrombosis: An unusual presentation of renal cell carcinoma - Abstract
May 5, 2011
BJUI Mini Reviews - A new patient-focused approach to the treatment of metastatic renal cell carcinoma: Establishing customized treatment options
May 5, 2011
Pazopanib for the treatment of renal cancer - Abstract
May 4, 2011
Everolimus for the treatment of advanced renal cell carcinoma - Abstract
May 4, 2011
Frequency of HCV infection in renal cell carcinoma patients - Abstract
May 3, 2011
Long-term response and postsurgical complete remissions after treatment with sunitinib malate, an oral multitargeted receptor tyrosine kinase inhibitor, in patients with metastatic renal cell carcinoma - Abstract
May 3, 2011
EAU 2011 - Partial and radical nephrectomy for pT1 renal cell carcinoma: Results of the SATURN project - Session Highlights
May 3, 2011
Patient-reported outcomes in a phase III study of everolimus versus placebo in patients with metastatic carcinoma of the kidney that has progressed on vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy - Abstract
May 2, 2011
Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma - Abstract
May 2, 2011
EAU 2011 - Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favourable MSKCC or ECOG prognostic features - Session Highlights
May 2, 2011
EAU 2011 - Prognostic factors in chromophobe renal cell carcinoma: Results from a retrospective multicenter series - Session Highlights
May 2, 2011
EAU 2011 - Treatment management of T1A renal cell carcinoma in the 21st century: A population-based analysis - Session Highlights
May 2, 2011
Incidence, predictors and associated outcomes of renal cell carcinoma in long-term dialysis patients - Abstract
April 29, 2011
Page 450 of 455
Start
Prev
445
446
447
448
449
450
451
452
453
454
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free
